Rosuvastatin use reduces thrombin generation potential in patients with venous thromboembolism: a randomized controlled trial

ESSENTIALS: The role of statins in hemostasis and venous thromboembolism (VTE) prophylaxis is not clear. This trial assessed whether rosuvastatin use affects thrombin generation in patients with VTE. Endogenous thrombin potential and peak were decreased by 10% and 5% with rosuvastatin therapy. These...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:J Thromb Haemost
Hauptverfasser: Orsi, Fernanda A., Biedermann, Joseph S., Kruip, Marieke J.H.A., van der Meer, Felix J., Rosendaal, Frits R., van Hylckama Vlieg, Astrid, Bos, Mettine H. A., Leebeek, Frank W. G., Cannegieter, Suzanne C., Lijfering, Willem M.
Format: Artigo
Sprache:Inglês
Veröffentlicht: John Wiley and Sons Inc. 2019
Schlagworte:
CLINICAL HEMOSTASIS AND THROMBOSIS
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6850636/
https://ncbi.nlm.nih.gov/pubmed/30565854
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/jth.14364
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge